ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,983,000 | -66.5% | 366,626 | -81.6% | 0.45% | -63.8% |
| Q1 2017 | $17,843,000 | -2.1% | 1,995,880 | -3.8% | 1.24% | -1.1% |
| Q4 2016 | $18,227,000 | +111.4% | 2,073,680 | +62.4% | 1.26% | +102.6% |
| Q3 2016 | $8,621,000 | +865.4% | 1,277,214 | +503.3% | 0.62% | +870.3% |
| Q4 2015 | $893,000 | -91.6% | 211,714 | -85.4% | 0.06% | -91.3% |
| Q1 2015 | $10,687,000 | – | 1,450,173 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
| Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
| First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
| Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
| KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
| Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
| EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
| Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |